Evaluation of infectious disease markers in multitransfused Egyptian children with thalassemia

Annals of Clinical and Laboratory Science

Volumn 44, Issue 1, 2014, Pages 62-66

  Hussein, Eiman ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS 1 ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS 2 ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; BIOLOGICAL MARKER;

ADOLESCENT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CHILD; CHILDHOOD DISEASE; CLINICAL EVALUATION; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID TESTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING TEST; THALASSEMIA INTERMEDIA; THALASSEMIA MAJOR; VASCULARIZATION; AGE DISTRIBUTION; BLOOD; COMMUNICABLE DISEASES; COMPLICATION; HEPACIVIRUS; INFANT; METABOLISM; PHYSIOLOGY; PRESCHOOL CHILD; THALASSEMIA; VIROLOGY;

ADOLESCENT; AGE DISTRIBUTION; BIOMARKERS; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES; EGYPT; FEMALE; HEPACIVIRUS; HEPATITIS B SURFACE ANTIGENS; HUMANS; INCIDENCE; INFANT; MALE; THALASSEMIA;

EID: 84897951825     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, El Khoby T, Abdel-Wahab Y, Aly Ohn ES, Anwar W, Sallam I. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000, 11 (Suppl 355):887-91.
2. Hussein E, Teruya J. Evaluation of blood supply operation and infectious disease markers in blood donors during the Egyptian revolution. Transfusion 2012, 52:2321-8.
3. Stramer SL, Glynn SA, Kleinman SH, Strong DM, Caglioti S, Wright DJ, Dodd RY, Busch MP. National Heart, Lung, and Blood Institute Nucleic Acid Test Study Group. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004;351:760-8.
4. Krajden M, Ziermann R, Khan A, Mak A, Leung K, Hendricks D, Comanor L. Qualitative detection of hepatitis C virus RNA. comparison of analytical sensitivity, clinical performance, and workflow of the Cobas Amplicor HCV test version 2.0 and the HCV RNA. J Clin Microbiol 2002,40(Suppl8):2903-7.
5. Cunningham MJ, Macklin EA, Neufeld EJ, Cohen AR. And the Thalassemia Clinical Research Network. Complications of B-thalassemia major in North America. Blood 2004. 104. 34-9.
6. Mirmomen S, Alavian SM, Hajarizadeh B, Kafaee J, Yektaparast B, Zahedi MJ, Zand V, Azami AA, Hosseini MM, Faridi AR, Davari K, Hajibeigi B. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran. a multicenter study. Arch Iran Med 2006;9:319-23.
7. Wanachiwanawin W, Luengrojanakul P, Sirangkapracha P, Leowattana W. Prevalence and clinical significance of hepatitis C virus infection in Thai patients with thalassemia. Int J Hematol 2003;78:374-8
8. Ocak S, Kaya H, Cetin M, Gali E, Ozturk. Seroprevalence of hepatitis B and hepatitis C in patients with thalassemia and sickle cell anemia in a long-term follow-up. Arch Med Res 2006;37:895-8.
9. Al-Kubaisy WA, Al-Naib KT, Habib M. Seroprevalence of hepatitis C virus specific antibodies among Iraqi children with thalassaemia. East Mediterr Health J 2006. 12. 204-10.
10. Chakrabarti S, Pradhan P, Roy A, Hira M, Bandyopadhyay G, Bhattacharya D. Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products. Indian J Public Health 2006. 50:43-4.
11. Leory V, Bourliere M, Durand M. et al. The antibody response to hepatitis B virus vaccination is negatively influenced by the negative hepatitis C virus viral load in patients with chronic hepatitis C. a case control study. Eur J Gasroentrol-Hepatol, 2002. 14(5). 485-9.
12. Singh H, Pradhan M, Singh RL, Phadke S, Naik SR, Aggarwal R. High frequency of hepatitis B virus infection in patients with beta-thalassemia receiving multiple transfusions. Vox Sang 2003,84:292-9.
13. Khakhkhar V, Joshi PJ. HBsAg seropositivity among multitransfused thalassemic children. Indian J Pathol Microbiol 2006. 49:516-8.
14. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990. 336:325-9.
15. Busch MP, Lee LL, Satten GA, Henrard DR, Farzadegan H, Nelson KE, Read S, Dodd RY, Petersen LR. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion. implications for screening of blood and tissue donors. Transfusion 1995. 35:91-7.
16. Roger Cho, Elizabeth C, Helfand M. Screening for hepatitis C virus infection. A review of the evidence for the US. preventive services task forces. Annals of internal medicine 2004;140. 465-79.
17. Carithers RL Jr, Marquardt A, Gretch DR. Diagnostic testing for hepatitis C. Semin Liver Dis 2000. 20:159-71.
18. Vrielink H, Reesink HW, Van den Burg PJ, Zaaijer HL, Cuypers HT, Lelie PN, van der Poel CL. Performance of three generations of anti-hepatitis C virus enzyme-linked immunosorbent assays in donors and patients. Transfusion 1997;37:845-9.
19. Cribier B, Rey D, Schmitt C, Lang JM, Kirn A, Stoll-Keller F. High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV.AIDS 1996;10:922-3.
20. Colin C,Lanior D,Touzet S, Meyaud-Kraemer L, Bailly F, Trepo C. Sensitivity and specificity of third generation hepatitis C virus antibody detection assays. an analysis of literature. J Vir Hep 2001. 8:87-95.
21. Gilson R, Brook MG. Hepatitis A, B, and C. sexually transmitted infections 2006;82:35-9.
22. Beld M., Habibuw MR, Rebers SP, Boom R, Reesink HW. Evaluation of automated RNA- extraction technology and a qualitative HCV assay for sensitivity and detection of HCV RNA in pool screening systems. Transfusion 2000;40:575-9.
23. Lee SC, Antony A,Lee N, Leibow J, Yang JQ, Soviero S, Gutekunst K, Rosenstraus M. Improved version 2.0 qualitative and quantitative Amplicor reverse transcription-PCR tests for hepatitis C virus RNA. calibration to international units, enhanced genotype reactivity, and performance characteristics. J Clin. Microbiol 2000;38:4171-9.
24. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996, 334:1685-90.
25. Busch M. Closing the windows on viral transmission by blood transfusion. blood safety in the new millennium. American Association of blood banks, Edited by Stramer SL, Bethesda. Md. 2001. 33-54.
26. Challine D, Pellegrin B, Bouvier-Alias M, Rigot P, Laperche L, Pawlotsky JM. Lancet. HIV and hepatitis C virus RNA in seronegative organ and tissue donors 2004;364:1611-2.
27. Radwan D, Moftah F, Goubran H, Mosa M, Ibrahem G. Over all representation of NAT results and correlation of NAT negativity with seropositive blood donors. Vox Sang 2010. 99. 87.1996;10:922-3.